cuidado com a hidroxicloroquinina da malária

Views: 0

“There are already other clinical studies that showed it is not effective against COVID-19 as well as several other viruses. And, more importantly, it can have dangerous side effects, as well as giving people false hope. The latter has led to widespread shortages of hydroxychloroquine for patients who need it to treat malaria, lupus and rheumatoid arthritis, the indications for which it was originally approved.”

The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.

The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.

Sobre CHRYS CHRYSTELLO

Chrys Chrystello jornalista, tradutor e presidente da direção da AICL
Esta entrada foi publicada em AICL Lusofonia Chrys Nini diversos. ligação permanente.